ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

Foundation Gives Duke $2M For Brain Tumor Research.

March 23, 2001

In Brief: Duke’s Gary Lyman to Co-Direct Fred Hutch Outcomes Research

January 10, 2014

Targeting Men At High Risk Finds More Head & Neck Cancer

September 24, 2010

Fewer Side Effects With IMRT Than Traditional Radiation

August 31, 2007

More Patients Get Screened, Colorectal Death Rates Drop

July 29, 2011

NCI Advisors Approve Center Grants For Research On Health Disparities.

November 30, 2001